Curetis, a Germany-based medical device company, has raised €12.5m ($15m) in its series B round from a consortium including Switzerland-based drugs company Roche’s corporate venturing unit.
Alongside Roche Venture Fund in the B round, were investment firm HBM Partners (founded by Henri B Meier, a former member of the Roche Group executive committee for more than 16 years), which invested €6m, Aeris Capital (the family office of Germany-based software provider SAP co-founder Klaus Tschira) and venture capital and state-backed firms LSP…
